Skip to main content
. 2021 Oct 12;11:20232. doi: 10.1038/s41598-021-99271-3

Table 1.

Demographic, comorbid, radiologic, histologic, and surgical characteristics of the 124 patients.

Variable Number % (p value)
Male 86 69.4(0.118)
Female 38 30.6(0.118)
Surgical procedures
Right-sided 74 59.7(0.368)
Left-sided 50 40.3(0.368)
Pneumonectomy 61 (right = 31, left = 30) 49.2(0.142)
Intrapericardial 7 5.6 (0.048)
Extrapleural 8 6.5 (0.242)
Completion 8 6.5 (0.999)
Bilobectomy 5 (RUL/RML = 1, RML/RLL = 4) 4.0(0.142)
Lobectomy 58 (RUL = 32, LUL = 18, RLL = 6, LLL = 2) 46.8(0.142)
Histologic type of tumors
Adenocarcinoma 51 41.1(0.673)
Squamous cell carcinoma 47 37.9(0.673)
Large cell carcinoma 10 8.1
Poorly differentiated carcinoma 11 8.9
Other carcinoma 5 4.0
Comorbidities
Chronic obstructive pulmonary disease 54 43.5(0.511)
Peripheral vascular disease 15 12.1(0.907)
Noninsulin-dependent diabetes mellitus 22 17.7(0.194)
Obesity 23 18.5(0.991)
Other malignancy 29 (7 = secondary primary lung carcinoma) 23.4
Coronary artery disease 30 24.2(0.290)
Hypertension 17 13.7(0.954)
Peptic disease 4 3.2 (0.347)
Chronic renal failure 3 2.4 (0.999)
Cerebrovascular accident 6 4.8 (0.417)
Hypothyroidism 3 2.4(0.543)
Liver disease 2 1.6
Drug/alcohol abuse 3 2.4
Chronic heart failure 5 4.0
Pulmonary edema 3 2.4
Chronic atrial fibrillation 3 2.4
Pretreatment staging
IIIA 91 73.4(0.812)
IIIB 33 26.6(0.812)
Smokers 110 88.7(0.556)
Type of induction treatment
Chemoradiation 85 68.5(0.066)
Chemotherapy 39 31.5(0.066)
PET-CT 92 74.2(0.001)

RUL right upper lobe, RML right middle lobe, RLL right lower lobe, LUL left upper lobe, LLL left lower lobe.